These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37571907)

  • 1. HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells.
    Shin MW; Seo SY; Kim SL; Kim SW
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):12-18. PubMed ID: 37571907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HDAC1 Inhibitor CBUD-1001 Enhances TRAIL-induced Apoptosis in Colorectal Cancer Cells.
    Shin MW; Kim SL; Yang HC; Yim SK; Seo SY; Lee ST; Kim HK; Kim SW
    Anticancer Res; 2021 Sep; 41(9):4353-4364. PubMed ID: 34475055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
    Pathil A; Armeanu S; Venturelli S; Mascagni P; Weiss TS; Gregor M; Lauer UM; Bitzer M
    Hepatology; 2006 Mar; 43(3):425-34. PubMed ID: 16583461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.
    Ding J; Polier G; Köhler R; Giaisi M; Krammer PH; Li-Weber M
    J Biol Chem; 2012 Jan; 287(1):641-649. PubMed ID: 22086925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
    Gupta SC; Francis SK; Nair MS; Mo YY; Aggarwal BB
    J Biol Chem; 2013 Nov; 288(45):32343-32356. PubMed ID: 24078627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
    Kim SL; Min IS; Park YR; Lee ST; Kim SW
    Int J Oncol; 2018 Dec; 53(6):2789-2799. PubMed ID: 30221676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
    Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ
    Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
    Lian B; Yang D; Liu Y; Shi G; Li J; Yan X; Jin K; Liu X; Zhao J; Shang W; Zhang R
    Cell Physiol Biochem; 2018; 49(6):2151-2162. PubMed ID: 30257253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
    Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells.
    Toriyama S; Horinaka M; Yasuda S; Taniguchi T; Aono Y; Takamura T; Morioka Y; Miki T; Ukimura O; Sakai T
    Mol Cancer Ther; 2016 Sep; 15(9):2066-75. PubMed ID: 27406983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.
    Bagci-Onder T; Agarwal A; Flusberg D; Wanningen S; Sorger P; Shah K
    Oncogene; 2013 Jun; 32(23):2818-27. PubMed ID: 22824792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
    Aguilera DG; Das CM; Sinnappah-Kang ND; Joyce C; Taylor PH; Wen S; Hasselblatt M; Paulus W; Fuller G; Wolff JE; Gopalakrishnan V
    J Neurooncol; 2009 Jul; 93(3):303-18. PubMed ID: 19148581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
    Nahacka Z; Svadlenka J; Peterka M; Ksandrova M; Benesova S; Neuzil J; Andera L
    Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):522-531. PubMed ID: 29278689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors.
    Sung B; Prasad S; Ravindran J; Yadav VR; Aggarwal BB
    Free Radic Biol Med; 2012 Nov; 53(10):1977-87. PubMed ID: 22922338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma.
    Singh TR; Shankar S; Srivastava RK
    Oncogene; 2005 Jul; 24(29):4609-23. PubMed ID: 15897906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG; Choi YH; Hyun JW; Kim GY
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation.
    Sophonnithiprasert T; Nilwarangkoon S; Nakamura Y; Watanapokasin R
    Int J Oncol; 2015 Dec; 47(6):2188-96. PubMed ID: 26499766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
    Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
    Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells.
    Nakata S; Yoshida T; Horinaka M; Shiraishi T; Wakada M; Sakai T
    Oncogene; 2004 Aug; 23(37):6261-71. PubMed ID: 15208660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells.
    Fröhlich LF; Mrakovcic M; Smole C; Lahiri P; Zatloukal K
    PLoS One; 2014; 9(3):e91558. PubMed ID: 24618889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.